Identification of a novel variant in phosphoglycerate kinase-1 (PGK1) in an African-American child (PGK1 Detroit)

References

• Bianconi E, Piovesan A, Facchin F. An estimation of the number of cells in the human body. Ann Hum Biol. 2013;40(6):463–471. doi:10.3109/03014460.2013.807878.
   PubMed Web of Science ®Google Scholar
• Wiback SJ, Palsson BO. Extreme pathway analysis of human red blood cell metabolism. Biophys J. 2002;83(2):808–818. doi:10.1016/S0006-3495(02)75210-7.
   PubMed Web of Science ®Google Scholar
• Beutler E. PGK deficiency. Br J Haematol. 2007;136(1):3–11. doi:10.1111/j.1365-2141.2006.06351.x.
   PubMed Web of Science ®Google Scholar
• Kraus AP, Langston MF, Lynch BL. Red cell phosphoglycerate kinase deficiency. A new cause of non-spherocytic hemolytic anemia. Biochem Biophys Res Commun. 1968;30(2):173–177. doi:10.1016/0006-291x(68)90466-x.
   PubMed Web of Science ®Google Scholar
• Chen SH, Malcolm LA, Yoshida A, Giblett ER. Phosphoglycerate kinase: an X-linked polymorphism in man. Am J Hum Genet. 1971;23(1):87–91.
   PubMed Web of Science ®Google Scholar
• Michelson a. M, Blake CC, Evans ST, Orkin SH. Structure of the human phosphoglycerate kinase gene and the intron-mediated evolution and dispersal of the nucleotide-binding domain. Proc Natl Acad Sci USA. 1985;82(20):6965–6969. doi:10.1073/pnas.82.20.6965.
   PubMed Web of Science ®Google Scholar
• Matsumaru S, Oguni H, Ogura H, et al. A novel PGK1 mutation associated with neurological dysfunction and the absence of episodes of hemolytic anemia or myoglobinuria. Intractable Rare Dis Res. 2017;6(2):132–136. doi:10.5582/irdr.2017.01020.
   PubMed Web of Science ®Google Scholar
• Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–249. doi:10.1038/nmeth0410-248.
   PubMed Web of Science ®Google Scholar
• Waterhouse A, Bertoni M, Bienert S, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296–W303. doi:10.1093/nar/gky427.
   PubMed Web of Science ®Google Scholar
• Guex N, Peitsch MC, Schwede T. Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective. Electrophoresis 2009;30(S1):S162–S73. doi:10.1002/elps.200900140.
   PubMed Web of Science ®Google Scholar
• Noel N, Flanagan J, Kalko SG, et al. Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain. Br J Haematol. 2006;132(4):051220022257015. doi:10.1111/j.1365-2141.2005.05882.x.
   Web of Science ®Google Scholar
• Ramírez-Bajo MJ, Repiso A, de la Ossa PP, et al. Enzymatic and metabolic characterization of the phosphoglycerate kinase deficiency associated with chronic hemolytic anemia caused by the PGK-Barcelona mutation. Blood Cells Mol Dis. 2011;46(3):206–211. doi:10.1016/j.bcmd.2010.12.009.
   PubMed Web of Science ®Google Scholar
• Maeda M, Yoshida A. Molecular defect of a phosphoglycerate kinase variant (PGK-Matsue) associated with hemolytic anemia: Leu—-Pro substitution caused by T/A—-C/G transition in exon 3. Blood 1991;77(6):1348–1352.
   PubMed Web of Science ®Google Scholar
• Tsujino S, Tonin P, Shanske S, et al. A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina). Ann Neurol. 1994;35(3):349–353. doi:10.1002/ana.410350316.
   PubMed Web of Science ®Google Scholar
• Fujii H, Kanno H, Hirono A, Shiomura T, Miwa S. A single amino acid substitution (157 Gly—-Val) in a phosphoglycerate kinase variant (PGK Shizuoka) associated with chronic hemolysis and myoglobinuria. Blood 1992;79(6):1582–1585.
   PubMed Web of Science ®Google Scholar
• Cohen-Solal M, Valentin C, Plassa F, et al. Identification of new mutations in two phosphoglycerate kinase (PGK) variants expressing different clinical syndromes: PGK Créteil and PGK Amiens. Blood 1994;84(3):898–903.
   PubMed Web of Science ®Google Scholar
• Turner G, Fletcher J, Elber J, Yanagawa Y, Dave V, Yoshida A. Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in a large kindred. Br J Haematol. 1995;91(1):60–65. doi:10.1111/j.1365-2141.1995.tb05245.x.
   PubMed Web of Science ®Google Scholar
• Flanagan JM, Rhodes M, Wilson M, Beutler E. The identification of a recurrent phosphoglycerate kinase mutation associated with chronic haemolytic anaemia and neurological dysfunction in a family from USA. Br J Haematol. 2006;134(2):233–237. doi:10.1111/j.1365-2141.2006.06143.x.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Twele TW, Davé V, Beutler E. Molecular abnormality of a phosphoglycerate kinase variant (PGK-Alabama). Blood Cells Mol Dis.1995;21(3):179–181. doi:10.1006/bcmd.1995.0020.
   PubMedGoogle Scholar
• Fujii H, Yoshida A. Molecular abnormality of phosphoglycerate kinase-Uppsala associated with chronic nonspherocytic hemolytic anemia. Proc Natl Acad Sci USA.1980;77(9):5461–5465. doi:10.1073/pnas.77.9.5461.
   PubMed Web of Science ®Google Scholar
• Svaasand EK, Aasly J, Landsem VM, Klungland H. Altered expression of PGK1 in a family with phosphoglycerate kinase deficiency. Muscle Nerve. 2007;36(5):679–684. doi:10.1002/mus.20859.
   PubMed Web of Science ®Google Scholar
• Hamano T, Mutoh T, Sugie H, Koga H, Kuriyama M. Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation. Neurology 2000;54(5):1188–1190. doi:10.1212/wnl.54.5.1188.
   PubMed Web of Science ®Google Scholar
• Ookawara T, Davé V, Willems P, et al. Retarded and aberrant splicings caused by single exon mutation in a phosphoglycerate kinase variant. Arch Biochem Biophys.1996;327(1):35–40. doi:10.1006/abbi.1996.0089.
   PubMed Web of Science ®Google Scholar
• Coppens S, Koralkova P, Aeby A, et al. Recurrent episodes of myoglobinuria, mental retardation and seizures but no hemolysis in two brothers with phosphoglycerate kinase deficiency. Neuromuscul Disord. 2016;26(3):207–210. doi:10.1016/j.nmd.2015.11.008.
   PubMed Web of Science ®Google Scholar
• Shirakawa K, Takahashi Y, Miyajima H. Intronic mutation in the PGK1 gene may cause recurrent myoglobinuria by aberrant splicing. Neurology 2006;66(6):925–927. doi:10.1212/01.wnl.0000203500.63884.39.
   PubMed Web of Science ®Google Scholar
• Sugie H, Sugie Y, Nishida M, et al. Recurrent myoglobinuria in a child with mental retardation: phosphoglycerate kinase deficiency. J Child Neurol. 1989;4(2):95–99. doi:10.1177/088307388900400203.
   PubMed Web of Science ®Google Scholar
• Kanno H, Fujii H, Hirono a, et al. Molecular analysis of glucose phosphate isomerase deficiency associated with hereditary hemolytic anemia. Blood 1996;88(6):2321–2325.
   PubMed Web of Science ®Google Scholar
• Fujii H, Krietsch WK, Yoshida A. A single amino acid substitution (Asp leads to Asn) in a phosphoglycerate kinase variant (PGK München) associated with enzyme deficiency. J Biol Chem. 1980;255(13):6421–6423.
   PubMed Web of Science ®Google Scholar
• Valentin C, Birgens H, Craescu CT, Brødum-Nielsen K, Cohen-Solal M. A phosphoglycerate kinase mutant (PGK Herlev; D285V) in a Danish patient with isolated chronic hemolytic anemia: mechanism of mutation and structure- function relationships. Hum Mutat. 1998;12(4):280–287. doi:10.1002/(SICI)1098-1004(1998)12:4<280::AID-HUMU10>3.0.CO;2-V.
   PubMed Web of Science ®Google Scholar
• Rosa R, George C, Fardeau M, Calvin MC, Rapin M, Rosa J. A new case of phosphoglycerate kinase deficiency: PGK Creteil associated with rhabdomyolysis and lacking hemolytic anemia. Blood 1982;60(1):84–91.
   PubMed Web of Science ®Google Scholar
• Maeda BM, Bawle EV, Kulkarni R, Beutler E, Yoshida A, Island G. Molecular Abnormalities of a Phosphoglycerate Kinase Variant Generated by Spontaneous Mutation. Blood 1992;79(10):2759–2763.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Watanabe S, Chen SH, Giblet ER, Malcolm LA. Human phosphoglycerate kinase. II. Structure of a variant enzyme. J Biol Chem. 1972;247(2):446–449.
   PubMed Web of Science ®Google Scholar
• Morimoto A, Ueda I, Hirashima Y, et al. A novel missense mutation (1060G –&gt; C) in the phosphoglycerate kinase gene in a Japanese boy with chronic haemolytic anaemia, developmental delay and rhabdomyolysis. Br J Haematol. 2003;122(6):1009–1013. doi:10.1046/j.1365-2141.2003.04543.x.
   PubMed Web of Science ®Google Scholar
• Fermo E, Bianchi P, Chiarelli LR, et al. A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization. Mol Genet Metab. 2012;106(4):455–461. doi:10.1016/j.ymgme.2012.05.015.
   PubMed Web of Science ®Google Scholar
• Sotiriou E, Greene P, Krishna S, Hirano M, DiMauro S. Myopathy and parkinsonism in phosphoglycerate kinase deficiency. Muscle Nerve. 2010;41(5):707–710. doi:10.1002/mus.21612.
   PubMed Web of Science ®Google Scholar
• Spiegel R, Gomez EA, Akman HO, Krishna S, Horovitz Y, DiMauro S. Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations. Neuromuscul Disord. 2009;19(3):207–211. doi:10.1016/j.nmd.2008.12.004.
   PubMed Web of Science ®Google Scholar
• Tamai M, Kawano T, Saito R, et al. Phosphoglycerate kinase deficiency due to a novel mutation (c. 1180A > G) manifesting as chronic hemolytic anemia in a Japanese boy. Int J Hematol. 2014;100(4):393–397. doi:10.1007/s12185-014-1615-x.
   PubMed Web of Science ®Google Scholar